138 176

Cited 0 times in

A National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma

DC FieldValueLanguage
dc.contributor.author김세훈-
dc.contributor.author윤홍인-
dc.contributor.author장종희-
dc.date.accessioned2020-06-17T01:03:23Z-
dc.date.available2020-06-17T01:03:23Z-
dc.date.issued2020-04-
dc.identifier.issn2288-2405-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/176229-
dc.description.abstractBackground: The Guideline Working Group of the Korean Society for Neuro-Oncology (KSNO) conducted a nationwide questionnaire survey for diverse queries faced in the treatment of brain tumors. As part II of the survey, the aim of this study is to evaluate the national patterns of clinical practice for patients with diffuse midline glioma and meningioma. Methods: A web-based survey was sent to all members of the KSNO by email. The survey included 4 questions of diffuse midline glioma and 6 questions of meningioma (including 2 case scenarios). All questions were developed by consensus of the Guideline Working Group. Results: In the survey about diffuse midline glioma, 76% respondents performed histologic confirmation to identify H3K27M mutation on immunohistochemical staining or sequencing methods. For treatment of diffuse midline glioma, respondents preferred concurrent chemoradiotherapy with temozolomide (TMZ) and adjuvant TMZ (63.8%) than radiotherapy alone (34.0%). In the survey about meningioma, respondents prefer wait-and-see policy for the asymptomatic small meningioma without peritumoral edema. However, a greater number of respondents had chosen surgical resection as the first choice for all large size meningiomas without exception, and small size meningiomas with either peritumoral edema or eloquent location. There was no single opinion with major consensus on long-term follow-up plans for asymptomatic meningioma with observation policy. As many as 68.1% of respondents answered that they would not add any adjuvant therapies for World Health Organization grade II meningiomas if the tumor was totally resected including dura. Conclusion: The survey demonstrates the prevailing clinical practice patterns for patients with diffuse midline glioma and meningioma among members of the KSNO. This information provides a point of reference for establishing a practical guideline in the management of diffuse midline glioma and meningioma.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Brain Tumor Society-
dc.relation.isPartOfBrain Tumor Research and Treatment-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleA National Consensus Survey for Current Practice in Brain Tumor Management II: Diffuse Midline Glioma and Meningioma-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Pathology (병리학교실)-
dc.contributor.googleauthorSung Kwon Kim-
dc.contributor.googleauthorHong In Yoon-
dc.contributor.googleauthorWan Soo Yoon-
dc.contributor.googleauthorJin Mo Cho-
dc.contributor.googleauthorJangsup Moon-
dc.contributor.googleauthorKyung Hwan Kim-
dc.contributor.googleauthorSe Hoon Kim-
dc.contributor.googleauthorYoung Il Kim-
dc.contributor.googleauthorYoung Zoon Kim-
dc.contributor.googleauthorHo Sung Kim-
dc.contributor.googleauthorYun Sik Dho-
dc.contributor.googleauthorJae Sung Park-
dc.contributor.googleauthorJi Eun Park-
dc.contributor.googleauthorYoungbeom Seo-
dc.contributor.googleauthorKyoung Su Sung-
dc.contributor.googleauthorJin Ho Song-
dc.contributor.googleauthorChan Woo Wee-
dc.contributor.googleauthorSe Hoon Lee-
dc.contributor.googleauthorDo Hoon Lim-
dc.contributor.googleauthorJung Ho Im-
dc.contributor.googleauthorJong Hee Chang-
dc.contributor.googleauthorMyung Hoon Han-
dc.contributor.googleauthorJe Beom Hong-
dc.contributor.googleauthorKihwan Hwang-
dc.contributor.googleauthorChul Kee Park-
dc.contributor.googleauthorYoun Soo Lee-
dc.contributor.googleauthorHo Shin Gwak-
dc.contributor.googleauthorKSNO Guideline Working Group-
dc.identifier.doi10.14791/btrt.2020.8.e6-
dc.contributor.localIdA00610-
dc.contributor.localIdA04777-
dc.contributor.localIdA04777-
dc.contributor.localIdA03470-
dc.contributor.localIdA03470-
dc.relation.journalcodeJ00398-
dc.identifier.eissn2288-2413-
dc.identifier.pmid32390349-
dc.subject.keywordBrain tumors-
dc.subject.keywordDiffuse midline glioma-
dc.subject.keywordKorean Society for Neuro-Oncology-
dc.subject.keywordMeningioma, Guideline Working Group-
dc.subject.keywordPractice patterns-
dc.contributor.alternativeNameKim, Se Hoon-
dc.contributor.affiliatedAuthor김세훈-
dc.contributor.affiliatedAuthor윤홍인-
dc.contributor.affiliatedAuthor윤홍인-
dc.contributor.affiliatedAuthor장종희-
dc.contributor.affiliatedAuthor장종희-
dc.citation.volume8-
dc.citation.number1-
dc.citation.startPage11-
dc.citation.endPage19-
dc.identifier.bibliographicCitationBrain Tumor Research and Treatment, Vol.8(1) : 11-19, 2020-04-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pathology (병리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.